Table 2.
ASB prevalence and causative organisms of SCD patients and healthy controls.
| Parameter | SCD Patients | Control Group | ||
|---|---|---|---|---|
| n | % | n | % | |
| Overall ASB prevalence | 19 | 17.3 | 9 | 8.2 |
| ASB prevalence in males | 1 | 2.4 | 1 | 2.4 |
| ASB prevalence in females | 18 | 26.5 | 8 | 11.8 |
| Causative organisms | ||||
| Coagulase negative Staphylococcus spp. | 4 | 3.6 | 5 | 4.5 |
| Escherichia coli | 4 | 3.6 | 2 | 1.8 |
| Enterobacter spp. | 3 | 2.7 | 0 | 0 |
| Streptococcus spp. | 3 | 2.7 | 1 | 0.9 |
| Staphylococcus aureus | 1 | 0.9 | 1 | 0.9 |
| Klebsiella oxytoca | 1 | 0.9 | 0 | 0 |
| Citrobacter spp. | 1 | 0.9 | 0 | 0 |
| Candida spp. | 1 | 0.9 | 0 | 0 |
“n”—number or frequency; SCD—sickle cell disease; ASB—asymptomatic bacteriuria. Parameters showing statistical significance were: difference in overall ASB prevalence of SCD patients and control group (p = 0.043); difference in ASB prevalence of SCD male and female patients (p = 0.001).